A61P 9/14
Vasoprotectives
Official title: Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
A61P9/14 (Vasoprotectives) appears on 2,743 US grants and 4,382 published applications in this corpus.
Search patents in A61P- Granted patents
- 2,743
- Published applications
- 4,382
- Assignees
- 1,670
- Inventors
- 8,548
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 1 | 0 |
| 1992 | 7 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 7 | 0 |
| 1997 | 18 | 0 |
| 1998 | 24 | 0 |
| 1999 | 25 | 0 |
| 2000 | 26 | 0 |
| 2001 | 39 | 11 |
| 2002 | 59 | 100 |
| 2003 | 71 | 156 |
| 2004 | 59 | 224 |
| 2005 | 61 | 241 |
| 2006 | 86 | 249 |
| 2007 | 84 | 268 |
| 2008 | 106 | 263 |
| 2009 | 119 | 313 |
| 2010 | 183 | 334 |
| 2011 | 153 | 248 |
| 2012 | 222 | 251 |
| 2013 | 185 | 200 |
| 2014 | 194 | 221 |
| 2015 | 147 | 183 |
| 2016 | 155 | 160 |
| 2017 | 128 | 153 |
| 2018 | 103 | 136 |
| 2019 | 99 | 142 |
| 2020 | 79 | 117 |
| 2021 | 65 | 98 |
| 2022 | 46 | 78 |
| 2023 | 59 | 78 |
| 2024 | 44 | 67 |
| 2025 | 34 | 56 |
| 2026 | 23 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Composition for improving vascular endothelial function15 Sep 2026US 12,734,187 B2San-Ei Gen F. F. I., Inc.
- Electrophilic compounds and electrophilic prodrugs for treating aneurysm8 Sep 2026US 12,728,111 B2The Regents of the University of Michigan
- Medical use of cystic fibrosis transmembrane conductance regulator (CFTR) modulators8 Sep 2026US 12,728,124 B2Borealis AG
- Anti-adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-IG scaffold for use in intervention and therapy of congestion in a patient in need thereof25 Aug 2026US 12,715,911 B2Adrenomed AG
- Lyophilized preparation of prostaglandin E1 methyl ester for injection and production and use thereof18 Aug 2026US 12,708,604 B2Xi'an Hanfeng Pharmaceutical Co., Ltd.
- Recombinant fusion protein for treatment of pulmonary hypertension8 Oct 2026US 2026/0308230 A1
- Targeted Nanomedicine for Treating Vascular Disorders1 Oct 2026US 2026/0294807 A1The University of Chicago
- Aryl-aniline and heteroaryl-aniline compounds for treatment of birthmarks24 Sep 2026US 2026/0284017 A1Nflection Therapeutics, Inc.
- Methods for enhancing vascular density24 Sep 2026US 2026/0284094 A1Metro International Biotech, LLC
- Novel sclerotherapy of venous blood vessels10 Sep 2026US 2026/0263656 A1Croma-Pharma GmbH
Most cited
By later US patents
- Stents261US 6,273,908 B12001
- Drug-delivery endovascular stent and method for treating restenosis244US 6,939,376 B2Sun Biomedical, Ltd. · 2005
- Anti-angiogenic compositions and methods of use242US 6,544,544 B2Angiotech Pharmaceuticals, Inc. · 2003
- Coronary vasculature treatment method230US 5,681,278 ACormedics Corp. · 1997
- Method for embolizing blood vessels219US 5,702,361 AMicro Therapeutics, Inc. · 1997